The latest biotech news - Labiotech.eu

Home News and Trends Page 310

Latest Posts

crispr charpentier ers genomics bayer blsc

News and Trends 18 May 2016

Bayer claims CRISPR Patents for Gene-Editing Agreements

Bayer has signed a patent license agreement with ERS Genomics, that controls patents for the CRISPR-Cas9 system – a breakthrough gene-editing technology. Bayer Lifescience Center (BLSC) is the innovation division of German Giant Bayer, which aims to address challenges in the pharmaceutical and agro-industry. Its strategy is to establish collaborations with innovative Biotechs, and create a […]

May 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

poland obama selvita epibiome microbiome ardigen

News and Trends 18 May 2016

Polish Bioinformatics company backs US movement into Microbiome Research

In Kraków, the Bioinformatics company Ardigen has now partnered up with a US based Microbiome startup, EpiBiome, which is looking for the answer to antibiotic resistance. This is another example of cross-Atlantic collaboration in the Microbiome world, just as President Obama pledges €105M ($121M) to the up and coming field of therapeutics. It’s a growing area of research, and as […]

May 18, 2016 - 2 minutesmins - By Philip Hemme

diabaetes insulin biotech islexa catapult uk trials aberdeen

News and Trends 18 May 2016

New UK Biotech could treat Diabetes with Lab-grown Cells

Islexa is the new baby of Catapult and the University of Aberdeen, which will be developing laboratory grown islets. This could replace insulin production in patients with type 1 diabetes. One of the coolest Biotechs in London, Catapult has joined the University of Aberdeen to create a new Biotech that could revolutionize treatment of type […]

May 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

imab ganymed gastroesophegal cancer asco

News and Trends 17 May 2016

‘Ideal’ German Antibodies have promising data for Gastro Cancer

Ganymed is presenting promising results of its phase II trial in gastroesophageal cancer at the ASCO Annual meeting 2016 in Chicago, one of the leading Oncology conferences worldwide. Based in Mainz (Germany), Ganymed is a Biopharma developing immunotherapies to tackle cancer, having joined forces with BioNTech (Germany’s larget private Biotech) 2 years ago to create […]

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

sobi hemophilia clotting factor alprolix

News and Trends 17 May 2016

Rare Disease Biopharma can now sell Hemophilia treatment across whole of EU

Sobi has received market approval by the European Comission for Alprolix, a long-duration protein therapy that protects hemophilia B patients from uncontrolled bleeding. With a focus on rare diseases, Swedish Orphan Biovitrum (Sobi) has clinical programmes in diseases like alkaptonuria, tyrosinaemia and hemophilia – a disease with which Sobi is particularly invested. Its candidate for hemophilia […]

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

newron ind rett syndrome apnea

News and Trends 17 May 2016

New Italian Drug is FDA approved for trials in Rare Neurological Disease

Newron sees its Investigational New Drug application approved by the FDA. It can now begin clinical trials for Rett Syndrome patients – a rare neurological disorder. Based near Milan (Italy), Newron is a Biopharma developing therapies for diseases of the central nervous system (CNS). Last year it raised over €23M to advance its pipeline, which features candidates […]

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

seventure microbiome labiotech biotech fund eligo enterome microbiomics medicine

News and Trends 16 May 2016

Interviewing the Founder of the World #1 Microbiome Investment fund

Isabelle De Cremoux is the CEO and President of French VC fund Seventure Partners, famous for having opened Health for Life Capital, a €160M fund dedicated to the Microbiome. Having previously worked in the business development team of Pfizer as well as Fournier/Abbott, Isabelle created the lifesciences department when joining Seventure, which she manages as CEO […]

May 16, 2016 - 4 minutesmins - By Philip Hemme

ladybug biotech week lupus

News and Trends 14 May 2016

What Happened this Week? Lupus fight, CRO, Plant charger

1. Today is World Lupus Day! Meet the people who are fighting this Rare disease 2. This UK Company told us how they Optimise Drug Development and turn a Profit 3. Meeting the startup which uses Plants to charge your Smartphone 4. This Dutch Gene Therapy is on the shelf and seems to Work. But nobody is […]

May 14, 2016 - 1 minutemin - By Philip Hemme

abbvie bms empliciti multiple myeloma cancer immunooncology ema

News and Trends 13 May 2016

First and only antibody for Multiple Myeloma approved in EU

Bristol-Myers Squibb and AbbVie have announced that their co-development project for an antibody therapy against Multiple Myeloma has been approved in the EU after a successful Phase III trial. Empliciti (elotuzumab) has been developed for the treatment of multiple myeloma as combination therapy in patients who have received at least one prior therapy, now making it […]

May 13, 2016 - 3 minutesmins - By Dani Bancroft

avexxin header biotech week

News and Trends 13 May 2016

Biotech of the Week: Avexxin, reducing inflammatory diseases from far up in Norway

We’re not going particularly far this week and we aren’t even leaving Scandinavia! From Stockholm, we are crossing the border to Norway and go up North. Sadly it’s not the see the Northern Lights but to visit Trondheim, where Avexxin, our Biotech of the Week is located. City: Trondheim (Norway) Founded: 2005 Employees: 8 (as of […]

May 13, 2016 - 1 minutemin - By Joachim Eeckhout

adenoviral lentiviral cell lines gene therapy cevec aav cap rca free biotech

News and Trends 12 May 2016

German Biotech achieves next step for Gene Therapy production of Viral Vectors

Cologne based Cevec specialises in producing tailor-made recombinant glycoproteins and gene therapy vectors. Now it has announced a breakthrough in their adenoviral vectors used in Gene Therapy. The increasing number of gene therapy-based discovery programs in the biotech and pharma industry is driving a greater need for the scalable production of gene therapy vectors. Vectors are needed […]

May 12, 2016 - 2 minutesmins - By Dani Bancroft

dresden spermbot sperm nanotechnology biotech IFW

News and Trends 12 May 2016

Sperm Cells Enlisted as Nanobot Delivery Guys

Reserchears at IFW Dresden were trying to create a nanorobot for drug delivery and even gene manipulation. They ended up using one of the motors created by nature – the flagella of sperm cells. Drug delivery is a key part in the development of new drugs, and an active field of research with academy-industry partnerships. Examples of ideas […]

May 12, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT